Interesting developments at FDA after controversial approval of purported Alzheimers treatment:
Twitter Link
Very interesting issue in many different respects, but I thought this signal from expert advisors was especially interesting.
The aducan'tumab crisis
Interesting developments at FDA after controversial approval of purported Alzheimers treatment:
Twitter Link
Very interesting issue in many different respects, but I thought this signal from expert advisors was especially interesting.
"One day, we shall die. All the other days, we shall live."
Posting Permissions
Reply With Quote